Purdue's Sleep Aid Patents Are Obvious, Judge Rules

March 30, 2015

Law360, New York (March 30, 2015, 3:01 PM ET) -- A New Jersey federal judge on Friday found that Purdue Pharmaceutical Products LP’s three patents for sleep aid Intermezzo are invalid for obviousness, granting a win to Actavis Elizabeth LLC, Novel Laboratories Inc. and others whom Purdue sued over plans to market their own generic versions of the drug.

All Content © 2003‐2015, Portfolio Media, Inc.

Jake M. Holdreith

Partner

Member of the Executive Board

Related Publications

Spring 2020
ANDA Approvals
GENERICally Speaking Spring 2020
Spring 2020
ANDA Litigation Settlements
GENERICally Speaking Spring 2020
Spring 2020
Generic Launches
GENERICally Speaking Spring 2020
Spring 2020
New ANDA Cases
GENERICally Speaking Spring 2020
March 31, 2020
Belcher Pharms., LLC v. Hospira, Inc.
GENERICally Speaking Spring 2020
Back to Top